Health
The second study that tested a COVID-19 antibody has a setback – AlKhaleej Today
The second study that tested a COVID-19 antibody has a setback
For the second time, a study testing an experimental antibody drug for COVID-19 has been suspended to investigate a possible safety issue in hospitalized patients.Regeneron Pharmaceuticals Inc. said Friday that independent observers had recommended that the most critically ill patients those who require intensive oxygen treatment or breathing apparatus be put on hold because of a potential safety issue and an adverse balance of risks and benefits. The study can continue to test the combination of…
-
Noosa News20 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Business20 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s